Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2016/0222092 NON-HUMAN MAMMALS FOR THE PRODUCTION OF CHIMERIC ANTIBODIES
The invention provides knock-in non-human cells and mammals having a genome encoding chimeric antibodies and methods of producing knock-in cells and mammals....
2016/0222091 NON-HUMAN MAMMALS FOR THE PRODUCTION OF CHIMERIC ANTIBODIES
The invention provides knock-in non-human cells and mammals having a genome encoding chimeric antibodies and methods of producing knock-in cells and mammals....
2016/0222090 NON-HUMAN MAMMALS FOR THE PRODUCTION OF CHIMERIC ANTIBODIES
The invention provides knock-in non-human cells and mammals having a genome encoding chimeric antibodies and methods of producing knock-in cells and mammals....
2016/0222089 COMPOSITIONS COMPRISING THE NC2 DOMAIN OF COLLAGEN IX AND METHODS OF USING SAME
The present invention relates to the newly identified timerization initiating and stagger determining capacity of the NC2 domain of collagen IX. The invention...
2016/0222088 RECOMBINANT CLUSTERIN AND USE THEREOF IN THE TREATMENT AND PREVENTION OF DISEASE
Recombinant clusterin polypeptides and compositions comprising the same are provided. In some aspects, recombinant clusterin or nucleic acids encoding the same...
2016/0222087 ALBUMIN VARIANTS
The present invention relates to variants of a parent albumin; the variants comprise one or more mutations in Domain II of albumin which lead to a change in...
2016/0222086 Conjugated Factor VIII Molecules
The present invention relates to B-domain truncated Factor VIII molecules with a modified circulatory half-life, said molecule being covalently conjugated with...
2016/0222085 COMPOSITIONS AND METHODS FOR MODULATING THROMBIN GENERATION
Factor V peptides and methods of use thereof are disclosed.
2016/0222084 Compositions Comprising D-Amino Acid Peptides and Methods of Production and Use Thereof for Inhibiting...
Compositions are disclosed that include D-amino acid peptides and that are capable of specifically binding to at least one autoantibody against a G-protein...
2016/0222083 ANTI-ENDOGLIN ANTIBODIES AND KNOCKIN MICE EXPRESSING NOVEL HUMAN/MOUSE CHIMERIC ENDOGLIN
Provided are compositions and methods that relate to prophylaxis and therapy of angiogenesis associated disease and includes novel knockin mice which express...
2016/0222082 FUSION PROTEIN
The present invention relates to a p75NTR neurotrophin binding protein(NBP)-Fc fusion protein comprising a p75N-TR(NBP) portion and an immunoglobulin portion....
2016/0222081 Fc-BINDING PROTEIN, METHOD FOR PRODUCING SAID PROTEIN, AND ANTIBODY ADSORBENT USING SAID PROTEIN, AND METHODS...
The present invention addresses the first problem of providing an Fc-binding protein having improved stability, especially stability to heat and acid, of the...
2016/0222080 MULTIPLE TARGET T CELL RECEPTOR
The present invention is directed to a functional T cell receptor (TCR) fusion protein (TFP) recognizing and binding to at least one MHC-presented epitope, and...
2016/0222079 Long-Acting Blood Sugar Decreasing Fusion Protein
The present invention provides an anthropogenic glucagon-like peptide-1 (GLP-1) recombinant protein molecule fused with an anthropogenic immunoglobulin subtype...
2016/0222078 VIP FRAGMENTS AND METHODS OF USE
The invention relates to composition comprising a pharmaceutically effective amount of one or more functional vasoactive intestinal peptide (VIP) fragments,...
2016/0222077 COMPOSITION COMPRISING PEPTIDE DERIVED FROM ADIPONECTIN
Provided is a pharmaceutical or cosmetic composition comprising adiponectin-derived peptide fragments, i.e., the peptides of SEQ ID NOs: 1 to 6 as an active...
2016/0222076 HEPCIDIN ANALOGUES AND USES THEREOF
The present invention relates, inter alia, to certain hepcidin peptide analogues, including peptides and dimers thereof, and to the use of the peptides and...
2016/0222075 PRODUCTION OF GLYCOPROTEINS USING MANGANESE
Culture media comprising manganese and methods of culturing cells to improve sialylation and glycosylation of glycoproteins are provided.
2016/0222074 ALPHA-FETOPROTEIN "RING AND TAIL" PEPTIDES
The invention relates to compounds that are analogs of a cyclic peptide, cyclo[EKTOVNOGN], AFPep, that has anti-estrotrophic activity. The analogs of the...
2016/0222073 OPSIN POLYPEPTIDES AND METHODS OF USE THEREOF
The present disclosure provides opsins, including variant opsins with increased activity and/or increased trafficking to the plasma membrane. The opsins are...
2016/0222072 Universal Protein Tag for Double Stranded Nucleic Acid Delivery
Disclosed herein are chimeric proteins that include one or more double stranded nucleic acid binding domains (dsNABD) and one or more polyHis domains, and...
2016/0222071 ANALOGS OF SODIUM CHANNEL PEPTIDE TOXIN
The present invention relates to a peptide and analogs thereof that selectively inhibit the Na.sub.v1.7 sodium channel. The present invention also relates to...
2016/0222070 COMPOUNDS AND METHODS FOR DIAGNOSIS AND IMMUNOTHERAPY OF TUBERCULOSIS
Compounds and methods for diagnosing tuberculosis or for inducing protective immunity against tuberculosis are disclosed. The compounds provided include...
2016/0222069 PROTEINS WITH REPETITIVE BACTERIAL-IG-LIKE (BIG) DOMAINS PRESENT IN LEPTOSPIRA SPECIES
The invention relates to three isolated DNA molecules that encode for proteins, BigL1, BigL2 and BigL3, in the Leptospira sp bacterium which have repetitive...
2016/0222068 CONSTRUCTS FOR EXPRESSING BIOLOGICAL MOLECULES THAT INTEGRATE INTO BACTERIAL MICROCOMPARTMENTS
A conserved region of sequence in bacterial microcompartment (BMC) enzymes and proteins was identified. Peptide sequences derived from this conserved region of...
2016/0222067 NOVEL AAV'S AND USES THEREOF
The invention in some aspects relates to recombinant adeno-associated viruses having distinct tissue targeting capabilities. In some aspects, the invention...
2016/0222066 NOROVIRUS DERIVED IMMUNOGENIC COMPOSITIONS AND METHODS
The invention relates to chimeric norovirus VP1 proteins containing the S-domain of VP1 of a first norovirus strain and a P-domain that contains at least a...
2016/0222065 ANTIBODY LIKE PROTEIN
A general method and recombinant nucleic acid sequences, by means which the method selects a recombinant protein containing an FHA domain for binding a target...
2016/0222064 HYALURONIC ACID-BINDING SYNTHETIC PEPTIDOGLYCANS, PREPARATION, AND METHODS OF USE
This invention pertains to the field of hyaluronic acid-binding synthetic peptidoglycans and methods of forming and using the same.
2016/0222063 NOVEL POLYPEPTIDES
The present invention relates to polypeptides which are covalently bound to molecular scaffolds such that two or more peptide loops are subtended between...
2016/0222062 Cyclic Amino Acid Molecules And Methods Of Preparing The Same
Macrocyclization of amino acids or linear peptides upon reaction with amphoteric amino aldehydes and isocyanides is provided.
2016/0222061 Polymyxin Derivatives and Their Use in Combination Therapy Together with Different Antibiotics
Described are compounds of formula (I) for use in combination treatment with a second active agent, such as rifampicin, for example for treatment of a...
2016/0222060 Immunomodulators
The present disclosure provides novel macrocyclic peptides which inhibit the PD-1/PD-L1 and PD-L1/CD80 protein/protein interaction, and thus are useful for the...
2016/0222059 METHOD FOR PREPARING EPTIFIBATIDE
Provided is a method for preparing eptifibatide, wherein the method comprises: obtaining an eptifibatide refined peptide solution; and obtaining and...
2016/0222058 BIOACTIVE PEPTIDES AND METHODS OF PRODUCING AND USING THE SAME
Described herein are methods of identifying and releasing bioactive peptides from their full length proteins. The method involves (a) contacting the protein...
2016/0222057 COMPOUNDS FOR PROTEASOME ENZYME INHIBITION
Peptide-based compounds including heteroatom-containing, three-membered rings efficiently and selectively inhibit specific activities of N-terminal nucleophile...
2016/0222056 SUBSTITUTED PHENYLALANINE DERIVATIVES
The invention relates to substituted phenylalanine derivatives and to processes for preparation thereof, and to the use thereof for production of medicaments...
2016/0222055 METHOD FOR PRODUCING PROTEIN BY PRECIPITATION
The present invention provides a method for producing a target protein in the form of a fusion protein at a high recovery ratio. The present invention relates...
2016/0222054 PH SWITCHABLE REAGENTS AND METHODS FOR THEIR USE
This disclosure provides materials and methods for synthesis and use of pH switchable ligands.
2016/0222053 POLYMORPHIC FORM OF SODIUM HYODEOXYCHOLATE (NAHDC) AND ITS PREPARATION PROCESS
The object of the present invention is a new anhydrous polymorphic crystalline form of sodium hyodeoxycholate (NaHDC) named as form II (FII) and the process...
2016/0222052 DEUTERATED COMPOUNDS
Compounds of general formula (I) wherein (I) R1-R4 are each independently selected from H and deuterium; and at least one of R1-R4 is deuterium. The compounds...
2016/0222051 Self-Assembling Oligonucleotides and Methods
A composition comprising a double-stranded DNA filament having a plurality of single-species of oligonucleotide and chain terminator units, and a method for...
2016/0222050 MUTAGENIC NUCLEOSIDE ANALOGS AND USES THEREOF
The present disclosure provides nucleoside analogs of Formula (I) or (II). The nucleoside analogs are expected to show multiple tautomerism and may increase...
2016/0222049 Aminoglycoside Antibiotics with Reduced Ototoxicity
This disclosure relates generally to aminoglycoside derivatives of Formula (I) as described herein. The present disclosure also relates to pharmaceutical...
2016/0222048 AUTOMATED CARBOHYDRATE SYNTHESIS
The present invention provides a method of preparing an isolated oligosaccharide or glycolipid by preparing the oligosaccharide or glycolipid having a...
2016/0222047 C-ARYL GLUCOSIDE DERIVATIVE, PREPARATION METHODS THEREOF, AND MEDICAL APPLICATIONS THEREOF
C-aryl glucoside derivatives, preparation methods thereof, and medical applications thereof are described. Specifically, compounds represented by formula I,...
2016/0222046 CRYSTALLINE FORM OF 1-(BETA-D-GLUCOPYRANOSYL)-4-METHYL-3-[5-(4-FLUOROPHENYL)-2-THIENYLMETHYL]- BENZENE AND...
The present invention relates to a crystalline form of 1-(.beta.-d-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethy- l]benzene. Specifically, it...
2016/0222045 HIGH VALUE LIGNIN DERIVATIVES, POLYMERS, AND COPOLYMERS AND USE THEREOF IN THERMOPLASTIC, THERMOSET, COMPOSITE,...
The present disclosure relates to reactive modified lignin, methods of preparing such modified lignin, and materials, such as polymer systems, incorporating...
2016/0222044 ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME
An organometallic compound represented by Formula 1: M(L.sub.1).sub.n1(L.sub.2).sub.n2 Formula 1 wherein in Formula 1, M, L.sub.1, L.sub.2, n1, and n2 are the...
2016/0222043 METALLOINSERTOR CONJUGATES
A composition including a metalloinsertor conjugate that specifically targets mismatch repair (MMR)-deficient cells includes a complex represented by Formula...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.